Seismic Therapeutic Appoints Eric Larson as Senior Vice President of Finance and Heather Vital as Vice President of R&D Strategy - read this article along with other careers information, tips and advice on BioSpace
Seismic Therapeutic has raised $101m in Series A financing led by Lightspeed Venture Partners to advance its first two lead drug programmes to the clinic.
Machine learning is core to the drug research of Seismic Therapeutic, a new biotech startup developing novel drugs for immunology indications. CEO Jo Viney said the company’s initial focus is addressing dysregulation of adaptive immunity.
/PRNewswire/ LabCentral – with key support from AbbVie – today announced that Harmony and Nanopath were awarded the inaugural LabCentral Ignite Golden.